MedPath

Techniker Krankenkasse

🇩🇪Germany
Ownership
-
Established
1884-01-01
Employees
-
Market Cap
-
Website
https://www.tk.de/

Clinical Trials

10

Active:0
Completed:8

Trial Phases

1 Phases

Not Applicable:10

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials

Not Applicable
10 (100.0%)

Lifestyle Intervention in Chronic Ischemic Heart Disease and Diabetes

Not Applicable
Completed
Conditions
Ischemic Heart Disease Chronic
Diabetes Mellitus, Type 2
First Posted Date
2019-02-11
Last Posted Date
2021-11-05
Lead Sponsor
Techniker Krankenkasse
Target Recruit Count
502
Registration Number
NCT03835923
Locations
🇩🇪

University Hospital: Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany

🇩🇪

University Hospital: Charité - Universitätsmedizin Berlin, Berlin, Germany

🇩🇪

University Hospital: Herzzentrum Dresden, Dresden, Germany

and more 7 locations

News

Telemedicine-Based Lifestyle Intervention Shows Limited Benefits for Patients with CHD and Type 2 Diabetes

A 6-month telemedicine-supported lifestyle intervention program led to modest improvements in HbA1c levels and body weight in patients with coronary heart disease and type 2 diabetes.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.